studies – Pharma GMP

Hold Time Studies for Bulk Products and Intermediates

digi — Tue, 25 Nov 2025 17:42:04 +0000

Hold Time Studies for Bulk Products and Intermediates Comprehensive Step-by-Step Guide to Hold Time Studies for Bulk Products and Intermediates Effective management of hold time studies for bulk products and intermediates is critical within pharmaceutical manufacturing to ensure product quality, safety, and regulatory compliance. Holding bulk materials and intermediates for extended periods introduces risks of...

Case Studies: Failures in Uniformity of Dosage Units and CAPA

digi — Mon, 24 Nov 2025 23:03:42 +0000

Case Studies: Failures in Uniformity of Dosage Units and CAPA Case Studies: Failures in Uniformity of Dosage Units and Corrective Actions The uniformity of dosage units is a critical quality attribute in pharmaceutical manufacturing. Regulatory agencies such as the FDA, EMA, and MHRA mandate strict adherence to testing and control to ensure patient safety and...

How to Handle Deviations and Outliers in Hold Time Studies

digi — Mon, 24 Nov 2025 22:51:42 +0000

How to Handle Deviations and Outliers in Hold Time Studies Step-by-Step Guide to Handle Deviations and Outliers in Hold Time Studies Hold time studies are critical components of pharmaceutical manufacturing that validate the permissible period bulk materials or intermediates can be held before further processing without compromising product quality. Regulatory agencies such as the FDA,...

Case Studies: Recalls Triggered by Visual Defect Failures

digi — Mon, 24 Nov 2025 22:00:42 +0000

Case Studies: Recalls Triggered by Visual Defect Failures In-depth Step-by-Step Tutorial: Case Studies of Recalls Triggered by Visual Defect Failures in Pharmaceutical Manufacturing The pharmaceutical industry operates under strict Good Manufacturing Practice (GMP) regulations to ensure the safety, efficacy, and quality of medicinal products. One of the critical elements of GMP is the visual inspection...

Case Studies: Process Parameter Drift and Its Impact on Product Quality

digi — Mon, 24 Nov 2025 21:00:42 +0000

Case Studies: Process Parameter Drift and Its Impact on Product Quality In-Depth Case Studies on Process Parameter Drift and Its Effect on Pharmaceutical Product Quality In the pharmaceutical manufacturing industry, maintaining strict control over process parameters is essential to ensure consistent product quality, regulatory compliance, and patient safety. Process parameter drift—small deviations or gradual changes...

Case Studies: In-Process Control Failures in Tablet Manufacturing

digi — Mon, 24 Nov 2025 19:18:42 +0000

Case Studies: In-Process Control Failures in Tablet Manufacturing Comprehensive Step-by-Step Guide on Case Studies in Process Control Failures During Tablet Manufacturing The pharmaceutical industry relies heavily on stringent good manufacturing practices (GMP) to assure product quality, safety, and efficacy. One critical element within tablet manufacturing is the implementation and adherence to in-process control (IPC) checks....